Insider · CIK 0001676291

ERNST TIMOTHY S

Reports to the SEC for 1 company · HERCULES, CA

sec.gov

Transactions

Companies

Filings

CIK

0001676291

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2024-03-08	BIOBIO-RAD LABORATORIES, INC. · Non-Qualified Stock Option (right to buy)A Award	EVP, General Counsel & Sec	AAward	+2,357 sh	—	—	2,357
2024-02-28	BIOBIO-RAD LABORATORIES, INC.M Exercise/Conversion	EVP, General Counsel & Sec	MExercise/Conversion	+2,500 sh	$326.15	+$815K	5,897.478
2024-02-28	BIOBIO-RAD LABORATORIES, INC.S Sale	EVP, General Counsel & Sec	SSale	−2,500 sh	$330.55	−$826K	3,397.478
2024-02-28	BIOBIO-RAD LABORATORIES, INC. · Non-Qualified Stock Option (right to buy)M Exercise/Conversion	EVP, General Counsel & Sec	MExercise/Conversion	−2,500 sh	—	—	0
2023-09-04	BIOBIO-RAD LABORATORIES, INC.M Exercise/Conversion	EVP, General Counsel & Sec	MExercise/Conversion	+500 sh	—	—	3,631.797
2023-09-04	BIOBIO-RAD LABORATORIES, INC.F Tax Payment	EVP, General Counsel & Sec	FTax Payment	−248 sh	$394.60	−$97.9K	3,383.797
2023-09-04	BIOBIO-RAD LABORATORIES, INC. · Restricted Stock UnitsM Exercise/Conversion	EVP, General Counsel & Sec	MExercise/Conversion	−500 sh	—	—	0
2023-09-03	BIOBIO-RAD LABORATORIES, INC.M Exercise/Conversion	EVP, General Counsel & Sec	MExercise/Conversion	+464 sh	—	—	3,362.797
2023-09-03	BIOBIO-RAD LABORATORIES, INC.F Tax Payment	EVP, General Counsel & Sec	FTax Payment	−231 sh	$394.60	−$91.2K	3,131.797
2023-09-03	BIOBIO-RAD LABORATORIES, INC. · Restricted Stock UnitsM Exercise/Conversion	EVP, General Counsel & Sec	MExercise/Conversion	−464 sh	—	—	464
2023-09-02	BIOBIO-RAD LABORATORIES, INC.M Exercise/Conversion	EVP, General Counsel & Sec	MExercise/Conversion	+361 sh	—	—	3,077.797
2023-09-02	BIOBIO-RAD LABORATORIES, INC.F Tax Payment	EVP, General Counsel & Sec	FTax Payment	−179 sh	$394.60	−$70.6K	2,898.797
2023-09-02	BIOBIO-RAD LABORATORIES, INC. · Restricted Stock UnitsM Exercise/Conversion	EVP, General Counsel & Sec	MExercise/Conversion	−361 sh	—	—	361
2023-09-01	BIOBIO-RAD LABORATORIES, INC.F Tax Payment	EVP, General Counsel & Sec	FTax Payment	−173 sh	$394.60	−$68.3K	2,589.797
2023-09-01	BIOBIO-RAD LABORATORIES, INC.M Exercise/Conversion	EVP, General Counsel & Sec	MExercise/Conversion	+347 sh	—	—	2,762.797
2023-09-01	BIOBIO-RAD LABORATORIES, INC.M Exercise/Conversion	EVP, General Counsel & Sec	MExercise/Conversion	+253 sh	—	—	2,842.797
2023-09-01	BIOBIO-RAD LABORATORIES, INC.F Tax Payment	EVP, General Counsel & Sec	FTax Payment	−126 sh	$394.60	−$49.7K	2,716.797
2023-09-01	BIOBIO-RAD LABORATORIES, INC. · Restricted Stock UnitsA Award	EVP, General Counsel & Sec	AAward	+2,003 sh	—	—	2,003
2023-09-01	BIOBIO-RAD LABORATORIES, INC. · Restricted Stock UnitsM Exercise/Conversion	EVP, General Counsel & Sec	MExercise/Conversion	−347 sh	—	—	1,041
2023-09-01	BIOBIO-RAD LABORATORIES, INC. · Restricted Stock UnitsM Exercise/Conversion	EVP, General Counsel & Sec	MExercise/Conversion	−253 sh	—	—	507
2023-08-30	BIOBIO-RAD LABORATORIES, INC.M Exercise/Conversion	EVP, General Counsel & Sec	MExercise/Conversion	+2,350 sh	$215.98	+$508K	4,765.797
2023-08-30	BIOBIO-RAD LABORATORIES, INC.S Sale	EVP, General Counsel & Sec	SSale	−391 sh	$394.16	−$154K	4,374.797
2023-08-30	BIOBIO-RAD LABORATORIES, INC.S Sale	EVP, General Counsel & Sec	SSale	−1,582 sh	$395.76	−$626K	2,792.797
2023-08-30	BIOBIO-RAD LABORATORIES, INC.S Sale	EVP, General Counsel & Sec	SSale	−377 sh	$396.44	−$149K	2,415.797
2023-08-30	BIOBIO-RAD LABORATORIES, INC. · Non-Qualified Stock Option (right to buy)M Exercise/Conversion	EVP, General Counsel & Sec	MExercise/Conversion	−2,350 sh	—	—	0
2023-08-23	BIOBIO-RAD LABORATORIES, INC.S Sale	EVP, General Counsel & Sec	SSale	−300 sh	$384.69	−$115K	2,415.797
2023-03-08	BIOBIO-RAD LABORATORIES, INC.M Exercise/Conversion	EVP, General Counsel & Sec	MExercise/Conversion	+850 sh	$159.32	+$135K	4,267.364
2023-03-08	BIOBIO-RAD LABORATORIES, INC.M Exercise/Conversion	EVP, General Counsel & Sec	MExercise/Conversion	+150 sh	$215.98	+$32.4K	4,417.364
2023-03-08	BIOBIO-RAD LABORATORIES, INC.S Sale	EVP, General Counsel & Sec	SSale	−1,000 sh	$486.08	−$486K	3,417.364
2023-03-08	BIOBIO-RAD LABORATORIES, INC.S Sale	EVP, General Counsel & Sec	SSale	−746 sh	$486.89	−$363K	2,671.364
2023-03-08	BIOBIO-RAD LABORATORIES, INC. · Non-Qualified Stock Option (right to buy)M Exercise/Conversion	EVP, General Counsel & Sec	MExercise/Conversion	−850 sh	—	—	0
2023-03-08	BIOBIO-RAD LABORATORIES, INC. · Non-Qualified Stock Option (right to buy)M Exercise/Conversion	EVP, General Counsel & Sec	MExercise/Conversion	−150 sh	—	—	2,350
2022-09-05	BIOBIO-RAD LABORATORIES, INC.M Exercise/Conversion	EVP, General Counsel & Sec	MExercise/Conversion	+500 sh	—	—	3,653.213
2022-09-05	BIOBIO-RAD LABORATORIES, INC.F Tax Payment	EVP, General Counsel & Sec	FTax Payment	−248 sh	$478.32	−$119K	3,405.213
2022-09-05	BIOBIO-RAD LABORATORIES, INC. · Restricted Stock UnitsM Exercise/Conversion	EVP, General Counsel & Sec	MExercise/Conversion	−500 sh	—	—	0
2022-09-04	BIOBIO-RAD LABORATORIES, INC.M Exercise/Conversion	EVP, General Counsel & Sec	MExercise/Conversion	+500 sh	—	—	3,401.213
2022-09-04	BIOBIO-RAD LABORATORIES, INC.F Tax Payment	EVP, General Counsel & Sec	FTax Payment	−248 sh	$478.32	−$119K	3,153.213
2022-09-04	BIOBIO-RAD LABORATORIES, INC. · Restricted Stock UnitsM Exercise/Conversion	EVP, General Counsel & Sec	MExercise/Conversion	−500 sh	—	—	500
2022-09-03	BIOBIO-RAD LABORATORIES, INC.M Exercise/Conversion	EVP, General Counsel & Sec	MExercise/Conversion	+464 sh	—	—	3,062.213
2022-09-03	BIOBIO-RAD LABORATORIES, INC.F Tax Payment	EVP, General Counsel & Sec	FTax Payment	−161 sh	$478.32	−$77K	2,901.213
2022-09-03	BIOBIO-RAD LABORATORIES, INC. · Restricted Stock UnitsM Exercise/Conversion	EVP, General Counsel & Sec	MExercise/Conversion	−464 sh	—	—	928
2022-09-02	BIOBIO-RAD LABORATORIES, INC.M Exercise/Conversion	EVP, General Counsel & Sec	MExercise/Conversion	+361 sh	—	—	2,723.213
2022-09-02	BIOBIO-RAD LABORATORIES, INC.F Tax Payment	EVP, General Counsel & Sec	FTax Payment	−125 sh	$478.32	−$59.8K	2,598.213
2022-09-02	BIOBIO-RAD LABORATORIES, INC. · Restricted Stock UnitsM Exercise/Conversion	EVP, General Counsel & Sec	MExercise/Conversion	−361 sh	—	—	722
2022-09-01	BIOBIO-RAD LABORATORIES, INC.M Exercise/Conversion	EVP, General Counsel & Sec	MExercise/Conversion	+253 sh	—	—	2,450.213
2022-09-01	BIOBIO-RAD LABORATORIES, INC.F Tax Payment	EVP, General Counsel & Sec	FTax Payment	−88 sh	$486.25	−$42.8K	2,362.213
2022-09-01	BIOBIO-RAD LABORATORIES, INC. · Restricted Stock UnitsA Award	EVP, General Counsel & Sec	AAward	+1,388 sh	—	—	1,388
2022-09-01	BIOBIO-RAD LABORATORIES, INC. · Restricted Stock UnitsM Exercise/Conversion	EVP, General Counsel & Sec	MExercise/Conversion	−253 sh	—	—	760
2021-09-07	BIOBIO-RAD LABORATORIES, INC.M Exercise/Conversion	EVP, General Counsel & Sec	MExercise/Conversion	+500 sh	—	—	2,401.053
2021-09-07	BIOBIO-RAD LABORATORIES, INC.F Tax Payment	EVP, General Counsel & Sec	FTax Payment	−248 sh	$806.32	−$200K	2,153.053

Recent filings

Accepted (ET)
Mar 124
ERNST TIMOTHY S0001062993-24-006218
SEC(opens sec.gov)
Feb 294
ERNST TIMOTHY S0001062993-24-004959
SEC(opens sec.gov)
Sep 64
ERNST TIMOTHY S0001062993-23-017650
SEC(opens sec.gov)

Companies

BIO-RAD LABORATORIES, INC.EVP, General Counsel & SecBIO

Address

C/O BIO-RAD LABORATORIES, INC. 1000 ALFRED NOBEL DRIVE

HERCULES, CA, 94547